Background: Accumulating evidence has shown that disorders in the gut microbiota and
derived metabolites affect the development of atherosclerotic cardiovascular disease …

Over the past few decades, the treatment of atherosclerotic cardiovascular disease has
mainly been through an LDL lowering strategy and treatments targeting other traditional risk …

The gut microbiota plays an important role in controlling atherosclerosis progression to
support the link between the gut and coronary heart disease. Recent studies have shown …

Background Coronary artery disease (CAD) is associated with gut microbiota alterations in
different populations. Gut microbe-derived metabolites have been proposed as markers of …

Infections have been linked to the development of cardiovascular disease and
atherosclerosis. Findings from the past decade have identified microbial ecosystems …

Atherosclerosis is a leading cause of cardiovascular disease and mortality worldwide.
Alterations in the gut microbiota composition, known as gut dysbiosis, have been shown to …

Atherosclerosis remains the leading cause of death worldwide. Lifestyle modification,
including diet and exercise, is recommended to be the primary prevention strategy for …

Objective The metabolic influence of gut microbiota plays a pivotal role in the pathogenesis
of cardiometabolic diseases. Antibiotics affect intestinal bacterial diversity, and long-term …

In recent years, the importance of the gut microbiome in human health and disease has
increased. Growing evidence suggests that gut dysbiosis might be a crucial risk factor for …

The increasing prevalence of cardiovascular diseases cannot adequately be explained by
traditional risk factors. Recently, accumulating evidence has suggested that gut microbiota …